New combo therapy aims to turn liver tumors into cancer-fighting vaccines

NCT ID NCT06889610

Recruiting now Disease control Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Nov 21, 2025 · Last updated Apr 28, 2026 · Updated 20 times

Summary

This study tests a new approach for people with advanced breast, melanoma, or colorectal cancer that has spread to the liver. Doctors will use a special heat-based procedure to destroy some liver tumors, which may activate the immune system like a vaccine. Then, they add immunotherapy drugs to boost the body's ability to fight remaining cancer. The goal is to shrink tumors and control the disease longer. About 95 adults aged 18-80 with at least three liver tumors are being recruited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Fudan University Shanghai Cancer Center
RECRUITING

Shanghai, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

COLORECTAL CANCER METASTATIC MELANOMA METASTATIC TRIPLE NEGATIVE BREAST CANCER METASTATIC